Works matching IS 1342-1751 AND VI 25 AND IP 2 AND DT 2021
Results: 14
Validation of the diagnostic criteria for IgG4-related kidney disease (IgG4-RKD) 2011, and proposal of a new 2020 version.
- Published in:
- Clinical & Experimental Nephrology, 2021, v. 25, n. 2, p. 99, doi. 10.1007/s10157-020-01993-7
- By:
- Publication type:
- Article
InsKid—a new mobile application (app) that measures the infundibulopelvic angle before retrograde intrarenal surgery more reliably than does other approaches: pilot study.
- Published in:
- Clinical & Experimental Nephrology, 2021, v. 25, n. 2, p. 207, doi. 10.1007/s10157-020-01987-5
- By:
- Publication type:
- Article
Efficacy of continuous erythropoietin receptor activator for end-stage renal disease patients with renal anemia before and after peritoneal dialysis initiation.
- Published in:
- Clinical & Experimental Nephrology, 2021, v. 25, n. 2, p. 191, doi. 10.1007/s10157-020-01973-x
- By:
- Publication type:
- Article
Inpatient educational program delays the need for dialysis in patients with chronic kidney disease stage G5.
- Published in:
- Clinical & Experimental Nephrology, 2021, v. 25, n. 2, p. 166, doi. 10.1007/s10157-020-01979-5
- By:
- Publication type:
- Article
Screening of renal anomalies in first-degree relatives of children diagnosed with non-syndromic congenital anomalies of kidney and urinary tract.
- Published in:
- Clinical & Experimental Nephrology, 2021, v. 25, n. 2, p. 184, doi. 10.1007/s10157-020-01977-7
- By:
- Publication type:
- Article
Efficacy of once-daily cyclosporine in Japanese children with steroid-dependent minimal change nephrotic syndrome.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Association of neutrophil-to-lymphocyte ratio and risk of cardiovascular or all-cause mortality in chronic kidney disease: a meta-analysis.
- Published in:
- Clinical & Experimental Nephrology, 2021, v. 25, n. 2, p. 157, doi. 10.1007/s10157-020-01975-9
- By:
- Publication type:
- Article
Predictive factors and management of urinary tract infections after kidney transplantation: a retrospective cohort study.
- Published in:
- Clinical & Experimental Nephrology, 2021, v. 25, n. 2, p. 200, doi. 10.1007/s10157-020-01974-w
- By:
- Publication type:
- Article
Demographic, clinical and laboratory characteristics of rapidly progressive glomerulonephritis in Turkey: Turkish Society of Nephrology-Glomerular Diseases (TSN-GOLD) Working Group.
- Published in:
- Clinical & Experimental Nephrology, 2021, v. 25, n. 2, p. 173, doi. 10.1007/s10157-020-01978-6
- By:
- Publication type:
- Article
A phase 3 multicenter open-label maintenance study to investigate the long-term safety of sodium zirconium cyclosilicate in Japanese subjects with hyperkalemia.
- Published in:
- Clinical & Experimental Nephrology, 2021, v. 25, n. 2, p. 140, doi. 10.1007/s10157-020-01972-y
- By:
- Publication type:
- Article
Higher cardiovascular mortality in men with persistent dipstick hematuria.
- Published in:
- Clinical & Experimental Nephrology, 2021, v. 25, n. 2, p. 150, doi. 10.1007/s10157-020-01971-z
- By:
- Publication type:
- Article
Initial responsiveness to darbepoetin alfa and its contributing factors in non-dialysis chronic kidney disease patients in Japan.
- Published in:
- Clinical & Experimental Nephrology, 2021, v. 25, n. 2, p. 110, doi. 10.1007/s10157-020-01969-7
- By:
- Publication type:
- Article
Glucocorticoid treatment is associated with ICU-acquired hypernatremia: a nested case–control study.
- Published in:
- Clinical & Experimental Nephrology, 2021, v. 25, n. 2, p. 131, doi. 10.1007/s10157-020-01967-9
- By:
- Publication type:
- Article
Apararenone in patients with diabetic nephropathy: results of a randomized, double-blind, placebo-controlled phase 2 dose–response study and open-label extension study.
- Published in:
- Clinical & Experimental Nephrology, 2021, v. 25, n. 2, p. 120, doi. 10.1007/s10157-020-01963-z
- By:
- Publication type:
- Article